bf/NYSE:AMN_icon.png

NYSE:AMN

AMN Healthcare

  • Stock

USD

Last Close

18.43

06/11 22:30

Market Cap

1.79B

Beta: 0.33

Volume Today

1.05M

Avg: 757.17K

PE Ratio

10.09

PFCF: 6.08

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
44.06M
-
36.13M
18.01%
29.99M
16.99%
46.18M
54.00%
48.72M
5.50%
37.79M
22.44%
37.45M
0.92%
70.28M
87.69%
50.86M
27.64%
average payables
61.43M
-
86.48M
40.78%
97.40M
12.63%
79.29M
18.60%
77.82M
1.85%
92.49M
18.85%
105M
13.53%
223.23M
112.60%
356.17M
59.55%
358.58M
0.68%
average receivables
193.53M
-
275.36M
42.28%
362.03M
31.48%
391.54M
8.15%
403.76M
3.12%
420.71M
4.20%
437.74M
4.05%
739.47M
68.93%
986.61M
33.42%
842.78M
14.58%
book value per share
5.52
-
7.32
32.66%
9.37
28.05%
11.77
25.54%
13.49
14.64%
15.77
16.94%
17.28
9.57%
24.37
40.99%
23.40
3.96%
21.13
9.72%
capex per share
-0.41
-
-0.57
38.13%
-0.46
19.43%
-0.55
21.18%
-0.77
38.42%
-0.78
1.63%
-0.82
5.62%
-1.13
36.49%
-1.81
61.26%
-2.64
45.23%
capex to depreciation
-1.20
-
-1.29
7.75%
-0.74
42.50%
-0.82
10.87%
-0.88
7.36%
-0.62
29.39%
-0.42
33.36%
-0.52
24.65%
-0.59
14.05%
-0.64
9.17%
capex to operating cash flow
-0.69
-
-0.47
31.52%
-0.17
64.83%
-0.23
38.22%
-0.16
30.36%
-0.16
1.15%
-0.15
6.10%
-0.18
15.43%
-0.12
29.56%
-0.28
125.07%
capex to revenue
-0.02
-
-0.02
0.04%
-0.01
37.48%
-0.01
15.59%
-0.02
27.68%
-0.02
3.68%
-0.02
0.44%
-0.01
17.55%
-0.02
14.59%
-0.03
77.30%
cash per share
0.70
-
0.20
71.29%
0.87
333.80%
1.66
90.16%
1.54
7.05%
3.11
101.17%
1.91
38.56%
5.15
169.51%
2.82
45.21%
2.59
8.25%
days of inventory on hand
23.69
-
9.37
60.44%
9.81
4.62%
15.73
60.35%
10.02
36.26%
8.90
11.23%
8.85
0.53%
13.88
56.84%
days payables outstanding
32.20
-
40.20
24.83%
24.29
39.56%
19.88
18.17%
20.90
5.12%
25.31
21.13%
24.48
3.28%
46.26
88.96%
38.64
16.48%
46.58
20.54%
days sales outstanding
76.88
-
82.95
7.89%
75.13
9.42%
71.87
4.35%
71.09
1.08%
69.88
1.70%
68.63
1.78%
94.25
37.34%
65.74
30.25%
71.40
8.60%
debt to assets
0.24
-
0.25
4.22%
0.31
23.22%
0.40
29.97%
0.43
8.35%
0.37
13.17%
0.41
8.57%
0.28
31.81%
0.30
7.67%
0.45
49.67%
debt to equity
0.63
-
0.63
0.75%
0.81
28.59%
0.89
9.70%
1.01
13.55%
0.98
2.55%
1.17
18.90%
0.75
35.99%
0.82
10.56%
1.57
90.26%
dividend yield
earnings yield
0.04
-
0.06
52.28%
0.06
3.45%
0.06
1.93%
0.05
6.20%
0.04
25.83%
0.02
44.26%
0.06
157.07%
0.10
72.57%
0.07
26.16%
enterprise value
1.06B
-
1.68B
58.80%
2.20B
30.35%
2.66B
21.10%
3.11B
16.98%
3.55B
14.10%
4.16B
17.28%
6.52B
56.61%
5.38B
17.46%
4.22B
21.62%
enterprise value over ebitda
12.64
-
11.24
11.08%
9.92
11.73%
10.87
9.49%
12.75
17.30%
15.08
18.28%
17.20
14.09%
11.26
34.55%
6.90
38.72%
8.45
22.44%
ev to operating cash flow
38.33
-
29.53
22.96%
16.65
43.60%
23.07
38.53%
13.70
40.60%
15.79
15.18%
16.21
2.69%
21.35
31.72%
8.23
61.45%
11.33
37.67%
ev to sales
1.02
-
1.15
12.45%
1.15
0.26%
1.34
15.85%
1.46
8.90%
1.60
9.68%
1.74
8.88%
1.64
5.91%
1.03
37.28%
1.11
8.45%
free cash flow per share
0.18
-
0.63
244.07%
2.29
262.58%
1.86
19.02%
4.02
116.79%
4.03
0.26%
4.59
13.81%
5.28
14.97%
12.85
143.37%
6.82
46.87%
free cash flow yield
0.01
-
0.02
117.19%
0.06
192.80%
0.04
36.78%
0.07
88.44%
0.06
8.83%
0.07
3.90%
0.04
35.86%
0.12
189.55%
0.09
27.05%
graham net net
-4.42
-
-5.49
24.12%
-8.02
46.17%
-6.05
24.55%
-9.47
56.50%
-15.26
61.08%
-22.91
50.11%
-18.92
17.42%
-22.67
19.83%
-36.49
60.98%
graham number
9.42
-
16.85
78.89%
21.58
28.08%
27.09
25.58%
30.14
11.22%
29.43
2.33%
24.07
18.21%
61.35
154.88%
72.42
18.03%
50.46
30.32%
income quality
0.83
-
0.70
16.39%
1.25
78.81%
0.87
30.20%
1.60
84.18%
1.97
23.18%
3.63
84.24%
0.93
74.34%
1.47
57.84%
1.77
19.99%
intangibles to total assets
0.45
-
0.43
4.16%
0.49
14.76%
0.45
8.54%
0.51
13.15%
0.51
0.46%
0.61
18.02%
0.45
26.04%
0.49
8.85%
0.54
10.90%
interest coverage
7.35
-
16.54
125.05%
12.39
25.10%
10.80
12.87%
12.56
16.38%
6.22
50.47%
2.59
58.46%
14.03
442.62%
16.02
14.20%
7.13
55.46%
interest debt per share
3.69
-
4.76
29.02%
7.89
65.76%
10.84
37.30%
13.91
28.37%
16.07
15.55%
21.37
32.91%
18.90
11.55%
20.21
6.96%
34.37
70.03%
inventory turnover
15.40
-
38.94
152.76%
37.22
4.42%
23.21
37.64%
36.41
56.89%
41.02
12.66%
41.24
0.53%
26.29
36.24%
invested capital
0.63
-
0.63
0.75%
0.81
28.59%
0.89
9.70%
1.01
13.55%
0.98
2.55%
1.17
18.90%
0.75
35.99%
0.82
10.56%
1.57
90.26%
market cap
911.48M
-
1.48B
61.90%
1.84B
24.93%
2.35B
27.72%
2.68B
14.00%
2.91B
8.42%
3.24B
11.22%
5.83B
80.22%
4.58B
21.40%
2.95B
35.75%
net current asset value
-142.66M
-
-156.94M
10.01%
-286.87M
82.78%
-217.28M
24.26%
-371.56M
71.01%
-634.40M
70.74%
-1.00B
57.64%
-620.81M
37.92%
-751.07M
20.98%
-1.25B
66.62%
net debt to ebitda
1.78
-
1.39
21.65%
1.59
14.21%
1.25
21.81%
1.75
40.43%
2.72
55.30%
3.83
40.93%
1.18
69.04%
1.02
13.83%
2.55
149.46%
net income per share
0.71
-
1.72
141.24%
2.21
28.11%
2.77
25.61%
2.99
7.91%
2.44
18.43%
1.49
38.95%
6.87
360.76%
9.96
45.05%
5.36
46.22%
operating cash flow per share
0.60
-
1.20
101.70%
2.75
129.07%
2.41
12.33%
4.79
98.75%
4.81
0.48%
5.42
12.48%
6.40
18.25%
14.66
128.94%
9.46
35.47%
payables turnover
11.33
-
9.08
19.89%
15.02
65.46%
18.36
22.20%
17.47
4.87%
14.42
17.44%
14.91
3.39%
7.89
47.08%
9.45
19.74%
7.84
17.04%
receivables turnover
4.75
-
4.40
7.32%
4.86
10.40%
5.08
4.55%
5.13
1.10%
5.22
1.73%
5.32
1.81%
3.87
27.19%
5.55
43.37%
5.11
7.92%
research and ddevelopement to revenue
return on tangible assets
0.09
-
0.16
84.65%
0.18
7.96%
0.19
9.39%
0.19
0.79%
0.12
37.55%
0.08
37.10%
0.19
148.18%
0.30
58.51%
0.16
47.68%
revenue per share
22.28
-
30.79
38.18%
39.67
28.87%
41.59
4.84%
45.09
8.41%
47.58
5.51%
50.47
6.09%
83.55
65.53%
117.59
40.73%
96.32
18.09%
roe
0.13
-
0.24
81.84%
0.24
0.04%
0.24
0.05%
0.22
5.87%
0.15
30.25%
0.09
44.28%
0.28
226.80%
0.43
51.02%
0.25
40.43%
roic
0.09
-
0.15
67.70%
0.14
7.91%
0.14
2.84%
0.12
12.75%
0.09
27.73%
0.06
28.94%
0.17
178.20%
0.25
43.57%
0.12
52.35%
sales general and administrative to revenue
0.22
-
0.22
2.56%
0.21
4.08%
0.20
4.04%
0.21
5.34%
0.23
7.97%
0.23
0.45%
0.18
20.17%
0.18
2.57%
shareholders equity per share
5.52
-
7.32
32.66%
9.37
28.05%
11.77
25.54%
13.49
14.64%
15.77
16.94%
17.28
9.57%
24.37
40.99%
23.40
3.96%
21.13
9.72%
stock based compensation to revenue
0.01
-
0.01
1.75%
0.01
14.75%
0.01
14.09%
0.01
1.65%
0.01
44.36%
0.01
16.97%
0.01
25.97%
0.01
9.40%
0.00
17.07%
tangible asset value
-50.32M
-
-31.89M
36.63%
-138.09M
333.05%
-5.17M
96.26%
-125.66M
2,332.97%
-257.28M
104.74%
-609.72M
136.98%
-244.77M
59.85%
-368.56M
50.57%
-754.43M
104.69%
tangible book value per share
-1.08
-
-0.67
37.99%
-2.88
329.25%
-0.11
96.25%
-2.65
2,355.36%
-5.51
107.66%
-12.86
133.39%
-5.13
60.07%
-8.27
61.02%
-19.18
132.01%
working capital
104.38M
-
124.61M
19.39%
175.84M
41.11%
208.88M
18.79%
174.90M
16.27%
182.39M
4.29%
110.78M
39.26%
379.68M
242.74%
235.71M
37.92%
185.56M
21.28%

All numbers in USD (except ratios and percentages)